About Epigral Limited
Data last updated: 14 July 2026
Epigral Limited is a public limited company based in Ahmadabad City, Gujarat, India. It specialises in industrial chemicals, a part of the broader chemicals and materials sector. Incorporated on 11 September 2007, the company has been in operation for over 19 years.
Registered with ROC Ahmedabad under CIN L24100GJ2007PLC051717. Listed on BSE: 543332 and NSE: MFL.
Capital: an authorised share capital of ₹573.13 Cr and a paid-up capital of ₹43.14 Cr. It is led by directors including Sanjay Khatau Asher and Raju Swamy.
Last AGM: 28 June 2025. Financial statements filed for year ended 31 March 2025. Office: Ahmadabad City, Gujarat.
As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹2,527.18 Cr, a decline of 0.9% compared to the previous year. The net worth stands at ₹2,221.43 Cr (up 16.64% YoY). Total assets are valued at ₹3,505.3 Cr (up 11.19% YoY).
The company has a workforce of approximately 967 employees as per the latest available data.
The company is associated with 1 brand - Epigral. As per MCA filings, the company has open charges of ₹1,584.75 Cr and satisfied charges of ₹2,310.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website meghmanifinechem.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressEpigral Tower 5Th 6Th & 7Th Floor, B/H Safal Profitaire Corporate Road Prahladnagar, Ahmadabad City, Gujarat, India – 380015
-
IndustryChemicals and Materials, Industrial Chemicals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Epigral Limited
Epigral Limited has one previous CIN (Corporate Identification Number): U24100GJ2007PLC051717. The current CIN is L24100GJ2007PLC051717, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24100GJ2007PLC051717 | Current |
| U24100GJ2007PLC051717 | Previous |
Associated Brands with Epigral Limited
Epigral Limited operates one associated brand: Epigral. These brands represent Epigral Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Essential derivatives and specialty chemicals are manufactured for various industries. | epigral.com |
Business Activity of Epigral Limited
Epigral Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Epigral Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Epigral Limited
Epigral Limited is audited by S R B C & CO LLP (ICAI peer reviewed, certificate valid till 2029-02-28) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| S R B C & CO LLP (ICAI peer reviewed, certificate valid till 2029-02-28) | FY 2026 | Declaration of unmodified opinion |
Board of Directors and KMP of Epigral Limited
Epigral Limited currently reports 10 directors and 1 key managerial person. 11 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Sanjay Khatau Asher
Also directs:
Repro India Limited, Sudarshan Chemical Industries Limited, Gillette India Limited and 5 more
|
Director | 20 May 2021 | 5 Years 2 Months | Current |
| Raju Swamy | Director | 20 May 2021 | 5 Years 2 Months | Current |
|
Kanubhai Shakarabhai Patel
Also directs:
Voltamp Transformers Limited, Paramount Limited
|
Director | 20 May 2021 | 5 Years 2 Months | Current |
|
Karana Rameshbhai Patel
Also directs:
Meghmani Organics Limited, Navratan Specialty Chemicals Llp, Uniworth Enterprises Llp and 5 more
|
Director | 10 May 2016 | 10 Years 3 Months | Current |
|
Manubhai Khodidas Patel
Also directs:
Meghmani Organics Limited, Acme Diet Care Private Limited, Dialforhealth Unity Limited and 5 more
|
Director | 18 May 2017 | 9 Years 2 Months | Current |
|
Kaushal Ashishbhai Soparkar
Also directs:
Meghmani Organics Limited, Meghmani Crop Nutrition Limited, Kilburn Chemicals Limited and 4 more
|
Whole-Time Director | 10 May 2016 | 10 Years 3 Months | Current |
Financials of Epigral Limited FY 2026 filings available
Epigral Limited reported revenue of ₹2,527.18 Cr (down 0.9% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue from Operations | ₹2,527.18 Cr | ₹2,550.13 Cr | ₹1,929.19 Cr | ₹2,188.4 Cr | ₹1,550.94 Cr |
| Other Income | ₹14.98 Cr | ₹15.21 Cr | ₹6.52 Cr | ₹7.98 Cr | ₹4.11 Cr |
| Total Income | ₹2,542.16 Cr | ₹2,565.34 Cr | ₹1,935.71 Cr | ₹2,196.38 Cr | ₹1,555.05 Cr |
| Cost of Materials Consumed | ₹1,490.66 Cr | ₹1,322.4 Cr | ₹1,071.6 Cr | ₹1,211.76 Cr | ₹759.41 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹60.94 Cr | ₹31.09 Cr | -₹10.78 Cr | -₹96.97 Cr | ₹1.68 Cr |
| Employee Benefit Expense | ₹129.66 Cr | ₹114.48 Cr | ₹89.65 Cr | ₹86.6 Cr | ₹76.79 Cr |
| Finance Costs | ₹71.96 Cr | ₹53.27 Cr | ₹73.49 Cr | ₹65.5 Cr | ₹44.27 Cr |
| Depreciation & Amortisation | ₹168.29 Cr | ₹132.56 Cr | ₹123.56 Cr | ₹108.95 Cr | ₹85.91 Cr |
| Other Expenses | ₹400.73 Cr | ₹371.44 Cr | ₹297.51 Cr | ₹298.07 Cr | ₹203.57 Cr |
| Total Expenses | ₹2,200.36 Cr | ₹2,025.24 Cr | ₹1,645.03 Cr | ₹1,673.91 Cr | ₹1,171.63 Cr |
| Profit Before Exceptional Items & Tax | ₹341.8 Cr | ₹540.1 Cr | ₹290.67 Cr | ₹522.48 Cr | ₹383.42 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹341.8 Cr | ₹540.1 Cr | ₹290.67 Cr | ₹522.48 Cr | ₹383.42 Cr |
| Total Tax Expense | ₹8.79 Cr | ₹183.4 Cr | ₹94.88 Cr | ₹169.17 Cr | ₹130.64 Cr |
| Net Profit | ₹331.97 Cr | ₹357.69 Cr | ₹195.82 Cr | ₹353.29 Cr | ₹252.79 Cr |
| attributable to Owners | ₹331.97 Cr | ₹357.69 Cr | ₹195.82 Cr | ₹353.29 Cr | - |
| attributable to NCI | ₹0 | ₹0 | ₹0 | ₹0 | - |
| Other Comprehensive Income | ₹3 Lakh | -₹42 Lakh | -₹47.78 Lakh | ₹22.76 Lakh | -₹3.16 Lakh |
| Total Comprehensive Income | ₹332 Cr | ₹357.27 Cr | ₹195.34 Cr | ₹353.52 Cr | ₹252.76 Cr |
| EBITDA (computed) | ₹582.05 Cr | ₹725.93 Cr | ₹487.72 Cr | ₹696.93 Cr | ₹513.6 Cr |
| Basic EPS | ₹76.95 | ₹84.68 | ₹47.13 | ₹85.03 | ₹60.84 |
| Diluted EPS | ₹76.95 | ₹84.68 | ₹47.13 | ₹85.03 | ₹60.84 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹3,505.3 Cr | ₹3,152.44 Cr | ₹2,794.34 Cr | ₹2,432.24 Cr |
| Non-current Assets | ₹2,678.61 Cr | ₹2,377.2 Cr | ₹2,292.41 Cr | ₹2,012.74 Cr |
| Current Assets | ₹826.69 Cr | ₹775.24 Cr | ₹501.93 Cr | ₹419.5 Cr |
| Property, Plant & Equipment | ₹2,101.69 Cr | ₹2,219.29 Cr | ₹1,744.68 Cr | ₹1,778.86 Cr |
| Inventories | ₹348.63 Cr | ₹387.99 Cr | ₹262.99 Cr | ₹211.83 Cr |
| Trade Receivables | ₹416.53 Cr | ₹232.32 Cr | ₹178.75 Cr | ₹166.32 Cr |
| Cash & Equivalents | ₹5.02 Cr | ₹18.64 Cr | ₹3.18 Cr | ₹14.24 Cr |
| Equity (Net Worth) | ₹2,221.43 Cr | ₹1,904.53 Cr | ₹1,254.1 Cr | ₹1,069.1 Cr |
| Equity Share Capital | ₹43.14 Cr | ₹43.14 Cr | ₹41.55 Cr | ₹41.55 Cr |
| Borrowings (Non-current) | ₹333.69 Cr | ₹448.97 Cr | ₹547.04 Cr | ₹544.64 Cr |
| Borrowings (Current) | ₹229.3 Cr | ₹135.61 Cr | ₹415.65 Cr | ₹331.5 Cr |
| Total Debt (computed) | ₹562.99 Cr | ₹584.58 Cr | ₹962.69 Cr | ₹876.14 Cr |
| Current Liabilities | ₹710.42 Cr | ₹492.74 Cr | ₹779.57 Cr | ₹647.69 Cr |
| Total Liabilities | ₹1,283.87 Cr | ₹1,247.91 Cr | ₹1,540.24 Cr | ₹1,363.14 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹435.53 Cr | ₹440.56 Cr | ₹397.64 Cr | ₹626.16 Cr | ₹283.82 Cr |
| Investing Cash Flow | -₹354.67 Cr | -₹261.56 Cr | -₹401.1 Cr | -₹437.22 Cr | -₹454.63 Cr |
| Financing Cash Flow | -₹94.48 Cr | -₹163.54 Cr | -₹7.6 Cr | -₹199.79 Cr | ₹195.22 Cr |
| Capital Expenditure | ₹394.15 Cr | ₹194.69 Cr | ₹398.43 Cr | ₹416.45 Cr | ₹456.3 Cr |
| Free Cash Flow (computed) | ₹41.38 Cr | ₹245.87 Cr | -₹78.96 Lakh | ₹209.71 Cr | -₹172.48 Cr |
| Dividends Paid | ₹18.32 Cr | ₹31.54 Cr | ₹10.37 Cr | ₹24.22 Cr | ₹0 |
| Net Change in Cash | -₹13.62 Cr | ₹15.46 Cr | -₹11.06 Cr | -₹10.85 Cr | ₹24.41 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹736.16 Cr | ₹597.12 Cr | ₹587.36 Cr | ₹606.54 Cr | ₹627.63 Cr | ₹645.24 Cr | ₹626.06 Cr | ₹651.2 Cr | ₹524.63 Cr | ₹471.52 Cr | ₹478.15 Cr | ₹454.89 Cr |
| Other Income | -₹57 Lakh | ₹5.56 Cr | ₹1.74 Cr | ₹8.25 Cr | ₹3.4 Cr | ₹3.86 Cr | ₹5.55 Cr | ₹2.4 Cr | ₹1.52 Cr | ₹2.46 Cr | ₹1 Cr | ₹1.52 Cr |
| Total Income | ₹735.59 Cr | ₹602.68 Cr | ₹589.1 Cr | ₹614.79 Cr | ₹631.03 Cr | ₹649.1 Cr | ₹631.61 Cr | ₹653.6 Cr | ₹526.16 Cr | ₹473.98 Cr | ₹479.15 Cr | ₹456.42 Cr |
| Cost of Materials Consumed | ₹410.17 Cr | ₹413.45 Cr | ₹348.85 Cr | ₹318.19 Cr | ₹323.26 Cr | ₹329.07 Cr | ₹330.59 Cr | ₹339.48 Cr | ₹272.88 Cr | ₹276.43 Cr | ₹240.86 Cr | ₹281.43 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹14.85 Cr | -₹55.32 Cr | -₹21.35 Cr | ₹88 Lakh | ₹5.66 Cr | ₹3.68 Cr | ₹1.88 Cr | ₹19.87 Cr | -₹6.09 Cr | -₹28.53 Cr | ₹31.03 Cr | -₹7.19 Cr |
| Employee Benefit Expense | ₹36.54 Cr | ₹31.61 Cr | ₹31.47 Cr | ₹30.04 Cr | ₹31 Cr | ₹29.09 Cr | ₹26.99 Cr | ₹27.4 Cr | ₹25.52 Cr | ₹22.5 Cr | ₹20.83 Cr | ₹20.81 Cr |
| Finance Costs | ₹15.8 Cr | ₹10.95 Cr | ₹21.84 Cr | ₹23.37 Cr | ₹11.77 Cr | -₹7 Lakh | ₹27.32 Cr | ₹14.25 Cr | ₹13.69 Cr | ₹20.19 Cr | ₹21.27 Cr | ₹18.33 Cr |
| Depreciation & Amortisation | ₹41.69 Cr | ₹42.75 Cr | ₹42.31 Cr | ₹41.54 Cr | ₹33.95 Cr | ₹32.91 Cr | ₹32.25 Cr | ₹33.45 Cr | ₹30.38 Cr | ₹30.88 Cr | ₹31.51 Cr | ₹30.8 Cr |
| Other Expenses | ₹106.02 Cr | ₹104.64 Cr | ₹96.03 Cr | ₹94.04 Cr | ₹94.33 Cr | ₹100.89 Cr | ₹88.17 Cr | ₹88.05 Cr | ₹76.93 Cr | ₹78.36 Cr | ₹77.52 Cr | ₹64.66 Cr |
| Total Expenses | ₹625.07 Cr | ₹548.08 Cr | ₹519.15 Cr | ₹508.06 Cr | ₹499.97 Cr | ₹495.57 Cr | ₹507.2 Cr | ₹522.5 Cr | ₹413.3 Cr | ₹399.82 Cr | ₹423.02 Cr | ₹408.84 Cr |
| Profit Before Exceptional Items & Tax | ₹110.52 Cr | ₹54.6 Cr | ₹69.95 Cr | ₹106.73 Cr | ₹131.06 Cr | ₹153.53 Cr | ₹124.41 Cr | ₹131.1 Cr | ₹112.85 Cr | ₹74.16 Cr | ₹56.13 Cr | ₹47.58 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹110.52 Cr | ₹54.6 Cr | ₹69.95 Cr | ₹106.73 Cr | ₹131.06 Cr | ₹153.53 Cr | ₹124.41 Cr | ₹131.1 Cr | ₹112.85 Cr | ₹74.16 Cr | ₹56.13 Cr | ₹47.58 Cr |
| Total Tax Expense | ₹28.59 Cr | ₹15.45 Cr | ₹18.43 Cr | -₹53.68 Cr | ₹44.44 Cr | ₹49.99 Cr | ₹43.88 Cr | ₹45.09 Cr | ₹36.18 Cr | ₹24.85 Cr | ₹17.95 Cr | ₹15.9 Cr |
| Net Profit | ₹80.95 Cr | ₹39.11 Cr | ₹51.22 Cr | ₹160.69 Cr | ₹86.89 Cr | ₹103.63 Cr | ₹81.3 Cr | ₹85.87 Cr | ₹77.28 Cr | ₹49.08 Cr | ₹38 Cr | ₹31.51 Cr |
| attributable to Owners | ₹80.95 Cr | ₹39.11 Cr | ₹51.22 Cr | ₹160.69 Cr | ₹86.89 Cr | ₹103.63 Cr | ₹81.3 Cr | - | ₹77.28 Cr | ₹49.08 Cr | ₹38 Cr | - |
| attributable to NCI | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - | ₹0 | ₹0 | ₹0 | - |
| Other Comprehensive Income | ₹59 Lakh | -₹32 Lakh | -₹12 Lakh | -₹12 Lakh | -₹6 Lakh | -₹12 Lakh | -₹12 Lakh | -₹12 Lakh | -₹64.84 Lakh | ₹5.68 Lakh | ₹5.69 Lakh | ₹5.69 Lakh |
| Total Comprehensive Income | ₹81.54 Cr | ₹38.79 Cr | ₹51.1 Cr | ₹160.57 Cr | ₹86.83 Cr | ₹103.51 Cr | ₹81.18 Cr | ₹85.75 Cr | ₹76.63 Cr | ₹49.14 Cr | ₹38.05 Cr | ₹31.56 Cr |
| EBITDA (computed) | ₹168.01 Cr | ₹108.3 Cr | ₹134.1 Cr | ₹171.64 Cr | ₹176.78 Cr | ₹186.37 Cr | ₹183.98 Cr | ₹178.8 Cr | ₹156.91 Cr | ₹125.23 Cr | ₹108.91 Cr | ₹96.72 Cr |
| Basic EPS | ₹18.76 | ₹9.07 | ₹11.87 | ₹37.25 | ₹20.14 | ₹24.25 | ₹19.57 | ₹20.67 | ₹18.60 | ₹11.81 | ₹9.14 | ₹7.58 |
| Diluted EPS | ₹18.76 | ₹9.07 | ₹11.87 | ₹37.25 | ₹20.14 | ₹24.25 | ₹19.57 | ₹20.67 | ₹18.60 | ₹11.81 | ₹9.14 | ₹7.58 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue from Operations | ₹2,527.18 Cr | ₹2,550.13 Cr | ₹1,929.19 Cr | ₹2,188.4 Cr | ₹1,550.94 Cr |
| Other Income | ₹14.98 Cr | ₹15.21 Cr | ₹6.52 Cr | ₹7.98 Cr | ₹4.11 Cr |
| Total Income | ₹2,542.16 Cr | ₹2,565.34 Cr | ₹1,935.71 Cr | ₹2,196.38 Cr | ₹1,555.05 Cr |
| Cost of Materials Consumed | ₹1,490.66 Cr | ₹1,322.4 Cr | ₹1,071.6 Cr | ₹1,211.76 Cr | ₹759.41 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹60.94 Cr | ₹31.09 Cr | -₹10.78 Cr | -₹96.97 Cr | ₹1.68 Cr |
| Employee Benefit Expense | ₹129.66 Cr | ₹114.48 Cr | ₹89.65 Cr | ₹86.6 Cr | ₹76.79 Cr |
| Finance Costs | ₹71.96 Cr | ₹53.27 Cr | ₹73.49 Cr | ₹65.5 Cr | ₹44.27 Cr |
| Depreciation & Amortisation | ₹168.29 Cr | ₹132.56 Cr | ₹123.56 Cr | ₹108.95 Cr | ₹85.91 Cr |
| Other Expenses | ₹400.73 Cr | ₹371.44 Cr | ₹297.51 Cr | ₹298.02 Cr | ₹203.57 Cr |
| Total Expenses | ₹2,200.36 Cr | ₹2,025.24 Cr | ₹1,645.03 Cr | ₹1,673.86 Cr | ₹1,171.63 Cr |
| Profit Before Exceptional Items & Tax | ₹341.8 Cr | ₹540.1 Cr | ₹290.67 Cr | ₹522.53 Cr | ₹383.42 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹341.8 Cr | ₹540.1 Cr | ₹290.67 Cr | ₹522.53 Cr | ₹383.42 Cr |
| Total Tax Expense | ₹8.79 Cr | ₹183.4 Cr | ₹94.88 Cr | ₹169.17 Cr | ₹130.64 Cr |
| Net Profit | ₹333.01 Cr | ₹356.7 Cr | ₹195.79 Cr | ₹353.36 Cr | ₹252.79 Cr |
| Other Comprehensive Income | ₹3 Lakh | -₹42 Lakh | -₹47.78 Lakh | ₹22.76 Lakh | -₹3.16 Lakh |
| Total Comprehensive Income | ₹333.04 Cr | ₹356.28 Cr | ₹195.31 Cr | ₹353.59 Cr | ₹252.76 Cr |
| EBITDA (computed) | ₹582.05 Cr | ₹725.93 Cr | ₹487.72 Cr | ₹696.98 Cr | ₹513.6 Cr |
| Basic EPS | ₹77.19 | ₹84.45 | ₹47.12 | ₹85.04 | ₹60.84 |
| Diluted EPS | ₹77.19 | ₹84.45 | ₹47.12 | ₹85.04 | ₹60.84 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹3,505.34 Cr | ₹3,151.44 Cr | ₹2,794.33 Cr | ₹2,432.25 Cr |
| Non-current Assets | ₹2,678.65 Cr | ₹2,376.2 Cr | ₹2,292.4 Cr | ₹2,012.8 Cr |
| Current Assets | ₹826.69 Cr | ₹775.24 Cr | ₹501.93 Cr | ₹419.45 Cr |
| Property, Plant & Equipment | ₹2,101.69 Cr | ₹2,219.29 Cr | ₹1,744.68 Cr | ₹1,778.86 Cr |
| Inventories | ₹348.63 Cr | ₹387.99 Cr | ₹262.99 Cr | ₹211.83 Cr |
| Trade Receivables | ₹416.53 Cr | ₹232.32 Cr | ₹178.75 Cr | ₹166.32 Cr |
| Cash & Equivalents | ₹5.02 Cr | ₹18.64 Cr | ₹3.18 Cr | ₹14.19 Cr |
| Equity (Net Worth) | ₹2,221.47 Cr | ₹1,903.53 Cr | ₹1,254.09 Cr | ₹1,069.17 Cr |
| Equity Share Capital | ₹43.14 Cr | ₹43.14 Cr | ₹41.55 Cr | ₹41.55 Cr |
| Borrowings (Non-current) | ₹333.69 Cr | ₹448.97 Cr | ₹547.04 Cr | ₹544.64 Cr |
| Borrowings (Current) | ₹229.3 Cr | ₹135.61 Cr | ₹415.65 Cr | ₹331.5 Cr |
| Total Debt (computed) | ₹562.99 Cr | ₹584.58 Cr | ₹962.69 Cr | ₹876.14 Cr |
| Current Liabilities | ₹710.42 Cr | ₹492.74 Cr | ₹779.57 Cr | ₹647.64 Cr |
| Total Liabilities | ₹1,283.87 Cr | ₹1,247.91 Cr | ₹1,540.24 Cr | ₹1,363.09 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹435.53 Cr | ₹440.56 Cr | ₹397.69 Cr | ₹626.16 Cr | ₹283.82 Cr |
| Investing Cash Flow | -₹354.67 Cr | -₹261.56 Cr | -₹401.1 Cr | -₹437.22 Cr | -₹454.68 Cr |
| Financing Cash Flow | -₹94.48 Cr | -₹163.54 Cr | -₹7.6 Cr | -₹199.79 Cr | ₹195.22 Cr |
| Capital Expenditure | ₹394.15 Cr | ₹194.69 Cr | ₹398.43 Cr | ₹416.45 Cr | ₹456.3 Cr |
| Free Cash Flow (computed) | ₹41.38 Cr | ₹245.87 Cr | -₹73.96 Lakh | ₹209.71 Cr | -₹172.48 Cr |
| Dividends Paid | ₹18.32 Cr | ₹31.54 Cr | ₹10.37 Cr | ₹24.22 Cr | ₹0 |
| Net Change in Cash | -₹13.62 Cr | ₹15.46 Cr | -₹11.01 Cr | -₹10.85 Cr | ₹24.36 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹736.16 Cr | ₹597.12 Cr | ₹587.36 Cr | ₹606.54 Cr | ₹627.63 Cr | ₹645.24 Cr | ₹626.06 Cr | ₹651.2 Cr | ₹524.63 Cr | ₹471.52 Cr | ₹478.15 Cr | ₹454.89 Cr |
| Other Income | -₹57 Lakh | ₹5.56 Cr | ₹1.74 Cr | ₹8.25 Cr | ₹3.4 Cr | ₹3.86 Cr | ₹5.55 Cr | ₹2.4 Cr | ₹1.52 Cr | ₹2.46 Cr | ₹1 Cr | ₹1.52 Cr |
| Total Income | ₹735.59 Cr | ₹602.68 Cr | ₹589.1 Cr | ₹614.79 Cr | ₹631.03 Cr | ₹649.1 Cr | ₹631.61 Cr | ₹653.6 Cr | ₹526.16 Cr | ₹473.98 Cr | ₹479.15 Cr | ₹456.42 Cr |
| Cost of Materials Consumed | ₹410.17 Cr | ₹413.45 Cr | ₹348.85 Cr | ₹318.19 Cr | ₹323.26 Cr | ₹329.07 Cr | ₹330.59 Cr | ₹339.48 Cr | ₹272.88 Cr | ₹276.43 Cr | ₹240.86 Cr | ₹281.43 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹14.85 Cr | -₹55.32 Cr | -₹21.35 Cr | ₹88 Lakh | ₹5.66 Cr | ₹3.68 Cr | ₹1.88 Cr | ₹19.87 Cr | -₹6.09 Cr | -₹28.53 Cr | ₹31.03 Cr | -₹7.19 Cr |
| Employee Benefit Expense | ₹36.54 Cr | ₹31.61 Cr | ₹31.47 Cr | ₹30.04 Cr | ₹31 Cr | ₹29.09 Cr | ₹26.99 Cr | ₹27.4 Cr | ₹25.52 Cr | ₹22.5 Cr | ₹20.83 Cr | ₹20.81 Cr |
| Finance Costs | ₹15.8 Cr | ₹10.95 Cr | ₹21.84 Cr | ₹23.37 Cr | ₹11.77 Cr | -₹7 Lakh | ₹27.32 Cr | ₹14.25 Cr | ₹13.69 Cr | ₹20.19 Cr | ₹21.27 Cr | ₹18.33 Cr |
| Depreciation & Amortisation | ₹41.69 Cr | ₹42.75 Cr | ₹42.31 Cr | ₹41.54 Cr | ₹33.95 Cr | ₹32.91 Cr | ₹32.25 Cr | ₹33.45 Cr | ₹30.38 Cr | ₹30.88 Cr | ₹31.51 Cr | ₹30.8 Cr |
| Other Expenses | ₹106.02 Cr | ₹104.64 Cr | ₹96.03 Cr | ₹94.04 Cr | ₹94.33 Cr | ₹100.89 Cr | ₹88.17 Cr | ₹88.05 Cr | ₹76.93 Cr | ₹78.36 Cr | ₹77.57 Cr | ₹64.66 Cr |
| Total Expenses | ₹625.07 Cr | ₹548.08 Cr | ₹519.15 Cr | ₹508.06 Cr | ₹499.97 Cr | ₹495.57 Cr | ₹507.2 Cr | ₹522.5 Cr | ₹413.3 Cr | ₹399.82 Cr | ₹423.07 Cr | ₹408.84 Cr |
| Profit Before Exceptional Items & Tax | ₹110.52 Cr | ₹54.6 Cr | ₹69.95 Cr | ₹106.73 Cr | ₹131.06 Cr | ₹153.53 Cr | ₹124.41 Cr | ₹131.1 Cr | ₹112.85 Cr | ₹74.16 Cr | ₹56.08 Cr | ₹47.58 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹110.52 Cr | ₹54.6 Cr | ₹69.95 Cr | ₹106.73 Cr | ₹131.06 Cr | ₹153.53 Cr | ₹124.41 Cr | ₹131.1 Cr | ₹112.85 Cr | ₹74.16 Cr | ₹56.08 Cr | ₹47.58 Cr |
| Total Tax Expense | ₹28.59 Cr | ₹15.45 Cr | ₹18.43 Cr | -₹53.68 Cr | ₹44.44 Cr | ₹49.99 Cr | ₹43.88 Cr | ₹45.09 Cr | ₹36.18 Cr | ₹24.85 Cr | ₹17.95 Cr | ₹15.9 Cr |
| Net Profit | ₹81.93 Cr | ₹39.15 Cr | ₹51.52 Cr | ₹160.41 Cr | ₹86.62 Cr | ₹103.54 Cr | ₹80.53 Cr | ₹86.01 Cr | ₹76.67 Cr | ₹49.31 Cr | ₹38.13 Cr | ₹31.68 Cr |
| Other Comprehensive Income | ₹59 Lakh | -₹32 Lakh | -₹12 Lakh | -₹12 Lakh | -₹6 Lakh | -₹12 Lakh | -₹12 Lakh | -₹12 Lakh | -₹64.84 Lakh | ₹5.68 Lakh | ₹5.69 Lakh | ₹5.69 Lakh |
| Total Comprehensive Income | ₹82.52 Cr | ₹38.83 Cr | ₹51.4 Cr | ₹160.29 Cr | ₹86.56 Cr | ₹103.42 Cr | ₹80.41 Cr | ₹85.89 Cr | ₹76.02 Cr | ₹49.37 Cr | ₹38.19 Cr | ₹31.73 Cr |
| EBITDA (computed) | ₹168.01 Cr | ₹108.3 Cr | ₹134.1 Cr | ₹171.64 Cr | ₹176.78 Cr | ₹186.37 Cr | ₹183.98 Cr | ₹178.8 Cr | ₹156.91 Cr | ₹125.23 Cr | ₹108.86 Cr | ₹96.72 Cr |
| Basic EPS | ₹18.99 | ₹9.07 | ₹11.94 | ₹37.18 | ₹20.08 | ₹24.23 | ₹19.38 | ₹20.70 | ₹18.45 | ₹11.87 | ₹9.18 | ₹7.62 |
| Diluted EPS | ₹18.99 | ₹9.07 | ₹11.94 | ₹37.18 | ₹20.08 | ₹24.23 | ₹19.38 | ₹20.70 | ₹18.45 | ₹11.87 | ₹9.18 | ₹7.62 |
Shareholding Pattern of Epigral Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 68.83%, foreign institutional investors hold 1.54%, domestic institutional investors hold 4.90%, retail and other public shareholders hold 24.70% of Epigral Limited. The company had 77,583 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 68.83% | 68.83% | 68.83% | 68.83% | 68.95% | 68.94% |
| Public | 31.17% | 31.17% | 31.17% | 31.17% | 31.05% | 31.06% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | |
|---|---|---|---|---|---|
| Promoters | 68.83% | 68.95% | 71.49% | 71.34% | 71.18% |
| Public | 31.17% | 31.05% | 28.51% | 28.66% | 28.82% |
| Promoter change (YoY, %pts) | -0.12 | -2.54 | +0.15 | +0.16 | - |
Board & Governance of Epigral Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Epigral Limited has 10 directors - 5 independent and 2 executive. The board is chaired by Maulik Jayantibhai Patel.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Maulik Jayantibhai Patel | Executive Director · MD · Chairperson | 2016-05-10 | 2 |
| Kaushal Ashishbhai Soparkar | Executive Director · CEO | 2016-05-10 | 2 |
| Ankit Natwarlal Patel | Non-Executive - Non Independent Director | 2016-05-10 | 2 |
| Karana Rameshbhai Patel | Non-Executive - Non Independent Director | 2016-05-10 | 2 |
| Darshan Anandbhai Patel | Non-Executive - Non Independent Director | 2016-05-10 | 2 |
| Manubhai Khodidas Patel | Non-Executive - Independent Director | 2017-07-18 | 2 |
| Sanjay Khatau Asher | Non-Executive - Independent Director | 2021-05-20 | 7 |
| Kanubhai Shakara Patel | Non-Executive - Independent Director | 2021-05-20 | 2 |
| Raju Swamy | Non-Executive - Independent Director | 2021-05-20 | 1 |
| Priyanka Agarwal Chopra | Non-Executive - Independent Director | 2025-02-28 | 2 |
| Committee | Members |
|---|---|
| Audit Committee | Manubhai Khodidas Patel (Chairperson), Kanubhai Shakara Patel, Sanjay Khatau Asher |
| Nomination and remuneration committee | Raju Swamy (Chairperson), Manubhai Khodidas Patel, Sanjay Khatau Asher |
| Stakeholders Relationship Committee | Kanubhai Shakara Patel (Chairperson), Manubhai Khodidas Patel, Maulik Jayantibhai Patel |
| Risk Management Committee | Manubhai Khodidas Patel (Chairperson), Maulik Jayantibhai Patel, Kaushal Ashishbhai Soparkar |
| Corporate Social Responsibility Committee | Manubhai Khodidas Patel (Chairperson), Maulik Jayantibhai Patel, Kaushal Ashishbhai Soparkar |
Group Structure of Epigral Limited
Epigral Limited has 1 associated company. This group structure data is as of FY 2024. The corporate group structure reflects Epigral Limited's business expansion strategy and organizational complexity.
Charges & Borrowings of Epigral Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jun 2024 | Axis Bank Limited | ₹350 Cr | Open |
| 22 Apr 2024 | Axis Bank Limited | ₹350 Cr | Open |
| 18 Jun 2021 | Hdfc Bank Limited | ₹284.75 Cr | Open |
| 17 Jun 2013 | Others | ₹600 Cr | Open |
| 20 Feb 2021 | State Bank of India | ₹190 Cr | Satisfied |
Total charge records: 20 View all charges
Employees and EPFO Compliance at Epigral Limited
Epigral Limited has a workforce of 967 employees as of Dec 03, 2024.
Employee and EPFO history for Epigral Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Epigral Limited
GST registrations and filing compliance for Epigral Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Epigral Limited
Credit ratings, litigation, and regulatory alerts for Epigral Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Epigral Limited
MSME payment history for Epigral Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Epigral Limited
Corporate group structure for Epigral Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Epigral Limited
MCA filings and documents for Epigral Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Epigral Limited
Recent News on Epigral Limited
Frequently Asked Questions about Epigral Limited
Epigral Limited is an active public limited company in the chemicals and materials sector based in Ahmadabad City, Gujarat, India. It was incorporated on 11 September 2007 (19+ years old) and is registered under CIN L24100GJ2007PLC051717. Listed on BSE: 543332 and NSE: MFL. The company has 967 employees.
Epigral Limited reported revenue of ₹2,527.18 Cr for FY 2026 (down 0.9% YoY) based on consolidated NSE filings.
The current directors and KMP of Epigral Limited are:
- Sanjay Khatau Asher - Director
- Raju Swamy - Director
- Kanubhai Shakarabhai Patel - Director
- Karana Rameshbhai Patel - Director
- Manubhai Khodidas Patel - Director
- Kaushal Ashishbhai Soparkar - Whole-Time Director
- Maulik Jayantibhai Patel - Managing Director
- Darshan Anandbhai Patel - Director
- Ankit Natwarlal Patel - Director
- Priyanka Agarwal Chopra - Director
- Gaurang Ghanshyam Trivedi - Company Secretary
The primary industry of Epigral Limited is chemicals and materials. The company specifically operates in industrial chemicals. The company is currently active in this sector.
Yes. Epigral Limited is listed on both BSE (code: 543332) and NSE (symbol: MFL).
Epigral Limited can be reached at the registered office: Epigral Tower 5Th 6Th & 7Th Floor, BH Safal Profitaire Corporate Road Prahladnagar, Ahmadabad City, Gujarat, India – 380015, or through the website meghmanifinechem.com.